Source: Annual Congress 2010 - Pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. T. N. Lee, A. Peacock, M. Johnson (Glasgow, United Kingdom). The use of non-invasive stroke volume measurement to assess treatment response in pulmonary arterial hypertension. Eur Respir J 2010; 36: Suppl. 54, 4481

Member's Comments

No comment yet.

Related content which might interest you: The future of treatment for pulmonary arterial hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 The future of treatment for pulmonary arterial hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 The future of treatment for pulmonary arterial hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 The future of treatment for pulmonary arterial hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Noninvasive estimation of PVR using contrast enhanced MRI in patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 The effect of long-term specific therapy on clinical outcome, echocardiographic and sympatho-vagal balance as assessed by heart rate variability in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Value of MR-phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 424s Year: 2006 Dipyridamole as adjuvant therapy in patients with pulmonary arterial hypertension. A pilot study Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 Reliability of echo systolic pulmonary arterial pressure to detect new definition of pulmonary hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Cardiac function during exercise in pulmonary arterial hypertension Source: Annual Congress 2005 - Exercise in pulmonary hypertension Year: 2005 Noninvasive cardiac output measurements in patients with pulmonary hypertension Source: Eur Respir J 2013; 42: 125-133 Year: 2013 Hemodynamics as a substitute for exercise capacity endpoints in patients with pulmonary arterial hypertension (PAH): A model based assessment for sildenafil Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension Year: 2010 Early detection and management of pulmonary arterial hypertension Source: Eur Respir Rev 2012 21: 306-312 Year: 2012 A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis Source: Eur Respir J, 51 (1) 1701311; 10.1183/13993003.01311-2017 Year: 2018 A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension Source: Eur Respir J, 56 (3) 2000513; 10.1183/13993003.00513-2020 Year: 2020 The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Non-invasive hemodynamic assessment in patients with pulmonary hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008